Aclarion, Inc.
ACONW- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $3.08K in total; no superinvestor holds it.
Other share classesACON
Q3 2022 vs. Q2 2022
How the institutions holding Aclarion, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 5 | 7 | +2 |
| Shares | 858.9K | 955.7K | +96.8K (+11.3%) |
| Value | $289.0K | $327.0K | +$38.0K (+13.1%) |
New holders (2)
Institutions that held Aclarion, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Captrust Financial Advisors | 78,400 | $10.0K | 0.00% |
| UBS Group AG | 2,500 | $0 | 0.00% |
Sold out (0)
Institutions that held Aclarion, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.